Clinical trial data shows RAD 101 detects Brain Metastases

by admin February 10, 2025

February 10, 2025

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

5 Biggest Pharmaceutical ETFs in 2025

Canadian Election Candidates Unveil Plans to Fast Track...

Brightstar Completes Montague East Acquisition with BTR Group...

TNC Green-Lights Cloncurry Copper Project Mining Restart Plan...

L1X Corp announces Private Placement for the world’s...

Rio Tinto Plans US$1.8 Billion Investment in BS1...

High Resolution Ground Magnetics Commences at 100% –...

Lithium ION Energy Signs LOI with United Rare...

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

Trump’s Middle East trip leaves Netanyahu watching from the sidelines again
Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon
Falco Files Requested Documentation for the Horne 5 Project’s Environmental Authorization Process
Nuvau Minerals Completes High Resolution Drone MAG Survey
Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development

Categories

Business (1,634)
Investing (4,797)
Politics (7,568)
Uncategorized (2)
World (6,166)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

Clinical trial data shows RAD 101 detects Brain Metastases

MOU signed with Lafarge Canada Inc.

High-Grades up to 65g/t Au at Second Fortune Gold Mine

You may also like